In Vitro Activities of Telavancin and Six Comparator Agents against Anaerobic Bacterial Isolates-Reference-Cited by-同舟云学术

In Vitro Activities of Telavancin and Six Comparator Agents against Anaerobic Bacterial Isolates

Published:2009-09 Issue:9 Volume:53 Page:3996-4001
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Finegold Sydney M.¹²³,Bolanos Mauricio⁴,Sumannen Paula H.⁴,Molitoris Denise R.⁴

Affiliation:

1. Medical

2. Medicine

3. Microbiology, Immunology and Molecular Genetics, UCLA School of Medicine, Los Angeles, California

4. Research Services, Veterans Administration Greater Los Angeles Healthcare System, and Departments of

Abstract

ABSTRACT The antimicrobial activities of telavancin and six comparators were evaluated against 460 isolates of anaerobic bacteria. Telavancin demonstrated excellent activity against gram-positive anaerobes (MIC 90 , 2 μg/ml) and was the most potent agent tested against Clostridium difficile (MIC 90 , 0.25 μg/ml). As expected, gram-negative isolates were not inhibited by telavancin.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00908-08

Reference22 articles.

1. Aldridge, K. E. 1995. The occurrence, virulence, and antimicrobial resistance of anaerobes in polymicrobial infections. Am. J. Surg.169:2S-7S.

2. Daptomycin Pharmacokinetics and Safety following Administration of Escalating Doses Once Daily to Healthy Subjects

3. Finegold, S. M., D. Molitoris, Y. Song, C. Liu, M. L. Vaisanen, E. Bolte, M. McTeague, R. Sandler, H. Wexler, E. M. Marlowe, M. D. Collins, P. A. Lawson, P. Summanen, M. Baysallar, T. J. Tomzynski, E. Read, E. Johnson, R. Rolfe, P. Nasir, H. Shah, D. A. Haake, P. Manning, and A. Kaul. 2002. Gastrointestinal microflora studies in late-onset autism. Clin. Infect. Dis.35:S6-S16.

4. In Vitro Activities of the New Semisynthetic Glycopeptide Telavancin (TD-6424), Vancomycin, Daptomycin, Linezolid, and Four Comparator Agents against Anaerobic Gram-Positive Species and Corynebacterium spp

5. Hatano, K., K. Matsuzaki, Y. Sato, I. Kobayashi, and K. Yamaguchi. 2007. In vitro antimicrobial activity of telavancin against methicillin-resistant Staphylococcus aureus clinical isolates from Japan (2006). J. Antibiot. (Tokyo)60:709-712.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of novel antimicrobial agents on the normal functioning of human intestinal microbiota: a systematic review;Frontiers in Gastroenterology;2023-08-16

2. Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogens;Therapeutic Advances in Infectious Disease;2017-03

3. Telavancin in the treatment of Staphylococcus aureus hospital-acquired and ventilator-associated pneumonia: clinical evidence and experience;Therapeutic Advances in Respiratory Disease;2016-06-23

4. Pharmacodynamics, pharmacokinetics and clinical efficacy of telavancin in the treatment of pneumonia;Expert Opinion on Drug Metabolism & Toxicology;2016-05-30

5. The clinical positioning of telavancin in Europe;International Journal of Antimicrobial Agents;2015-03